top of page

Borderline Products: Medical Device or Medicinal Product? Principal Mode of Action, Rule 14 and ÜTS Registration

12 hours ago
8 min read
Sınır ürünler tıbbi cihaz mı ilaç mı asli etki mekanizması

SUMMARY

Borderline products are products that fall between a medical device and a medicinal product, cosmetic, biocidal product or food, and for which the applicable legislation needs to be clarified. The Medical Device Regulation (Tıbbi Cihaz Yönetmeliği) makes this distinction through the provisions of Articles 1 and 3.

In this article we give the definition of a medical device, the scope and exclusion provisions, the principal mode of action criterion, Annex VIII Rule 14 and the related field in the ÜTS product registration, quoting the regulation and the TİTCK ÜTS Registration Guideline TCKKD-KLVZ-03.

For the ÜTS registration of your medical device: Medical Device ÜTS Registration Consultancy

Contents

1. The Distinguishing Element in the Definition of a Medical Device

First sentence of Article 3, item (eee) of the Medical Device Regulation (Tıbbi Cihaz Yönetmeliği):

“1) A device whose intended principal function is not achieved by pharmacological, immunological or metabolic means in or on the human body, but which may be assisted in its function by such means, and which is specifically;”

In contrast, the definition of a human medicinal product in Article 4 of the TİTCK ÜTS Registration Guideline (ÜTS Kayıt Kılavuzu) is based on pharmacological, immunological or metabolic action:

“c) Human Medicinal Product: a substance or combination of substances presented as having properties for treating or preventing disease in humans, or used in or administered to humans to restore, correct or modify physiological functions by exerting a pharmacological, immunological or metabolic action, or to make a medical diagnosis,”

For the full definition, see our what is a medical device page.

2. Scope of the Regulation

Article 1, second and third paragraphs:

“(2) For the purposes of this Regulation, medical devices, medical device accessories and the products listed in Annex XVI to which this Regulation applies are hereinafter referred to as "devices".”

  • “a) All medical devices other than in vitro diagnostic devices,”

  • “c) Devices manufactured utilising non-viable animal tissues or cells, or their derivatives,”

  • “ç) Devices manufactured utilising derivatives of non-viable human tissues or cells”

Item (b) of the third paragraph also brings the Annex XVI product groups without a medical purpose into scope. For details, see our article on Annex XVI products without a medical purpose.

3. Products Outside the Scope

Article 1, fourth paragraph. This Regulation does not apply to the following products:

  • “b) (Amended: RG-29/7/2022-31907) Medicinal products as defined in item (b) of the first paragraph of Article 4 of the Human Medicinal Products Licensing Regulation published in the Official Gazette dated 11/12/2021 and numbered 31686,”

  • “d) Products within the scope of the Cosmetics Regulation published in the Official Gazette dated 23/5/2005 and numbered 25823,”

  • “g) Unlike the products referred to in items (ç), (e) and (f), products that contain or consist of viable biological material or viable organisms, including living micro-organisms, bacteria, fungi or viruses, in order to achieve or support the intended purpose of the product,”

  • “ğ) Foods within the scope of Law No. 5996 on Veterinary Services, Plant Health, Food and Feed dated 11/6/2010,”

The paragraph also lists IVD devices, advanced therapy medicinal products, blood and blood products, and animal and human transplants, tissues and cells. For all products outside the scope, see our article on products excluded from the MDR.

4. The Deciding Criterion: Principal Mode of Action

First sentence of Article 1, sixth paragraph:

“(6) In deciding whether a product falls within the scope of the Human Medicinal Products Licensing Regulation or this Regulation, particular account is taken of the principal mode of action of the product.”

The same paragraph draws a distinction for devices incorporating a substance regarded as a medicinal product:

“However, if that substance does not assist the function of the device but has a principal action, that integral product is subject to the Human Medicinal Products Licensing Regulation. In this case, the relevant general safety and performance requirements set out in Annex I to this Regulation apply as regards the safety and performance of the device part.”

According to the paragraph, if the substance assists the function of the device, the product is subject to the Medical Device Regulation; if the substance has a principal action, the integral product is subject to the Human Medicinal Products Licensing Regulation.

5. Devices Intended to Administer a Medicinal Product

Article 1, seventh paragraph:

“(7) Without prejudice to the provisions of the Human Medicinal Products Licensing Regulation concerning medicinal products, a device intended to administer a medicinal product defined in item (b) (Amended term: RG-29/7/2022-31907) of the first paragraph of Article 4 of that Regulation is subject to this Regulation.”

“However, if the device intended to administer a medicinal product and the medicinal product are placed on the market in such a way that they form a single integral product which is intended exclusively for use in the given combination and which is not reusable, that single integral product is subject to the Human Medicinal Products Licensing Regulation.”

Active devices that administer a medicinal product to the body are classified under Rule 12 of Annex VIII:

“All active devices intended to administer and/or remove medicinal products, body liquids or other substances to or from the body are classified as class IIa. However, they are classified as class IIb if this is done in a manner that is potentially hazardous, taking account of the nature of the substances involved, of the part of the body concerned and of the mode of application.”

6. Devices Incorporating an IVD Part or Human Tissue

Article 1, fifth paragraph:

“(5) A device which, when placed on the market or put into service, incorporates as an integral part an in vitro diagnostic device as defined in item (ü) of Article 3 of the In Vitro Diagnostic Medical Device Regulation is subject to the provisions of this Regulation. The provisions of the In Vitro Diagnostic Medical Device Regulation apply to the in vitro diagnostic device part of the device.”

The eighth paragraph applies the same approach to devices containing non-viable human tissues or cells:

“(8) Devices which, when placed on the market or put into service, incorporate as an integral part non-viable human tissues or cells or their derivatives in order to assist the function of the device are subject to the provisions of this Regulation.”

7. Classification: Rule 14 and Rule 21

Devices that contain a medicinal product are classified under Rule 14 of Annex VIII:

“All devices incorporating, as an integral part, a substance which, if used separately, can be considered to be a medicinal product as defined in item (b) (Amended term: RG-29/7/2022-31907) of Article 4 of the Human Medicinal Products Licensing Regulation, including a medicinal product derived from human blood or human plasma as defined in item (l) of Article 4 of the same Regulation, and that has an action ancillary to that of the devices, are classified as class III.”

Devices composed of substances that are absorbed by or locally dispersed in the human body fall under Rule 21:

“Devices that are composed of substances or of combinations of substances that are intended to be introduced into the human body via a body orifice or applied to the skin and that are absorbed by or locally dispersed in the human body:”

  • “- are classified as class III if they, or their products of metabolism, are systemically absorbed by the human body in order to achieve the intended purpose,”

  • “- are classified as class III if they achieve their intended purpose in the stomach or lower gastrointestinal tract and they, or their products of metabolism, are systemically absorbed by the human body,”

  • “- are classified as class IIa if they are applied to the skin or if they are applied in the nasal or oral cavity as far as the pharynx, and achieve their intended purpose on those cavities, and”

  • “- are classified as class IIb in all other cases.”

For the other rules, see our MDR risk class article.

8. Product in Doubt: Article 4

“ARTICLE 4 -(1) Where necessary, the Authority submits to the Commission a duly reasoned request to determine whether a specific product or category or group of products falls within the definition of "medical device" or "accessory for a medical device", or to clarify the regulatory status of products at the borderline between medical devices and medicinal products, human tissues and cells, cosmetic products, biocidal products or food products.”

“(2) The Authority shares expertise concerning products within its remit so that the Commission can determine the legislation applicable to a product or category or group of products.”

For a short answer, see our page on who decides on a borderline product.

9. A Device Containing a Medicinal Product in ÜTS

Article 27 of the TİTCK ÜTS Registration Guideline, on the field "Tıbbi ürün olarak kabul edilen bir madde ihtiva ediyor mu?" (Does it contain a substance regarded as a medicinal product?) in the MDR product registration:

  • “1) This field is mandatory to select in ÜTS.”

  • “2) This field is selected as "Evet" (Yes) if the relevant device contains one or more human medicinal products, and as "Hayır" (No) if it contains no human medicinal product.”

  • “3) If the device contains a human medicinal product, this information must appear on the label and/or sales packaging and in the instructions for use, and this field must be selected as "Evet".”

  • “4) If the device contains a substance that is considered a medicinal product when used separately, the name of this substance must appear on the label and/or sales packaging and in the instructions for use.”

“5) If the device contains a human medicinal product, this device is a Class III medical device under the classification rule referred to in MDR Annex VIII and in item (a) of the sixth paragraph of Article 56 of this Guideline, and its conformity assessment is carried out by a notified body, under the conformity assessment procedures referred to in Article 52 of the MDR and Article 61 of this Guideline that are appropriate for Class III.”

The same article has a separate field for a medicinal product derived from human blood or plasma, which is completed on the same principles. For the other fields of the registration screen, see our ÜTS product registration article.

10. Frequently Asked Questions

How is it determined whether a product is a medicinal product or a device?

According to the sixth paragraph of Article 1, particular account is taken of the principal mode of action of the product. A medical device does not achieve its principal function by pharmacological, immunological or metabolic means.

Which class is a device containing a medicinal product?

Devices that incorporate, as an integral part, a substance that can be considered a medicinal product and that assists the function of the device are class III under Rule 14 of Annex VIII. If the substance has a principal action, the product is subject to the Human Medicinal Products Licensing Regulation.

Which legislation applies to a syringe supplied together with a medicinal product as a single product?

Under the seventh paragraph of Article 1, if the device and the medicinal product are placed on the market as a single, non-reusable integral product intended exclusively for use in that combination, the product is subject to the Human Medicinal Products Licensing Regulation. A device intended to administer a medicinal product on its own is subject to the Medical Device Regulation.

Do cosmetic products fall under this Regulation?

No. Under item (d) of the fourth paragraph of Article 1, the Medical Device Regulation does not apply to products within the scope of the Cosmetics Regulation.

Who decides on a product at the borderline?

Under Article 4, the Authority submits to the Commission its reasoned request to determine whether a product falls within the definition, or to clarify the regulatory status of borderline products.

For the ÜTS registration of your medical device: Medical Device ÜTS Registration Consultancy

Sources

 
 

Medical Device ÜTS Registration Consultancy

Request an ÜTS registration consultancy quote

Ehlibeyt Mahallesi, Tekstilciler Caddesi No: 35/7 06520 Çankaya / Ankara - TÜRKİYE

Cevizli Mahallesi, Zuhal Caddesi Ritim İstanbul B Blok, No:44 Maltepe / İstanbul - TÜRKİYE

info@medexmedikal.com
+90 505 580 4622
+90 312 389 1354

ÜTS Guides · Legislation Calendar · Glossary · ÜTS Guide Index · Frequently Asked Questions

Services: ÜTS Consultancy · Who Carries Out the ÜTS Registration? · ÜTS Document Registration Consultancy · ÜTS Product Registration Consultancy · Importer ÜTS Registration Consultancy · Sales Centre Authorisation Certificate · EUDAMED Registration Consultancy · MDR/IVDR Declaration of Conformity · Technical File Preliminary Review · Label and Instructions for Use Check · PRRC Service · PMS and PSUR · Clinical Evaluation · EMDN and GMDN Code Determination · Certificate of Free Sale · EUDAMED XML Generator · ÜTS Registration Training · Correction of a Rejected ÜTS Application

KVKK and Privacy Policy | Cookie Policy | Accessibility Statement

© 2026 Medex Kurumsal Danışmanlık Ltd. Şti.

bottom of page
WhatsApp Hemen Ara